Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page’s displayed software revision has been updated to the next release (from v3.5.2 to v3.5.3), indicating a backend/site version change rather than an update to the clinical trial details.SummaryDifference0.1%

- Check8 days agoChange DetectedFooter shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded revision label v3.5.0. Removed revision label v3.4.3.SummaryDifference0.1%

- Check44 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 was added, and the prior notice about government funding lapse and NIH operating status was removed (associated with Revision: v3.4.1).SummaryDifference0.5%

- Check80 days agoChange DetectedBanner notice informs users about a lapse in government funding and that the NIH Clinical Center is open, with status updates available at opm.gov. Site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.